• Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 17 Feb 2025 02:11:12   America/Chicago


    Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 17, 2025 Share Link copied to clipboard. Shares of Rocket Pharmaceuticals, Inc.
    Read more...
Share on,